Applying lipidomics to non-alcoholic fatty liver disease: a clinical perspective
File(s)
Published version
Author(s)
Type
Journal Article
Abstract
The prevalence of Non-alcoholic fatty liver disease (NAFLD) and associated complications, such as hepatocellular carcinoma (HCC), is growing worldwide, due to the epidemics of metabolic risk factors, such as obesity and type II diabetes. Among other factors, an aberrant lipid metabolism represents a crucial step in the pathogenesis of NAFLD and the development of HCC in this population. In this review, we summarize the evidence supporting the application of translational lipidomics in NAFLD patients and NAFLD associated HCC in clinical practice.
Date Issued
2023-04
Date Acceptance
2023-04-20
Citation
Nutrients, 2023, 15 (8)
ISSN
2072-6643
Publisher
MDPI AG
Journal / Book Title
Nutrients
Volume
15
Issue
8
Copyright Statement
© 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
License URL
Identifier
https://www.mdpi.com/2072-6643/15/8/1992
Subjects
fibrosis
lipidomics
NAFLD
NASH
Publication Status
Published
Article Number
1992
Date Publish Online
2023-04-20